556NewsGeorge Liu, a veteran commodity trader, has been named the new Head of Derivatives at Babel Finance
SINGAPORE – Media OutReach – 23 February 2022 – George Liu has been named head of derivatives at Babel Trading by crypto...
- 686News
Zurich Hong Kong integrates ESG strategy into ILAS Scooping awards in Benchmark Wealth Management Awards 2021
Zurich Hong Kong is committed to sustainability and integrates ESG into its product development strategy Its newest Investment-Linked Assurance Scheme has the...
- 595News
KJFEM, Previously OCS Facilities Management, Now Offers Energy Management Solutions
SINGAPORE – Media OutReach – 23 February 2022 – Formerly an industrial and commercial cleaning services company, OCS Facilities Management has been...
- 729Wire Stories
Australians say flexible work is more important than career progression
Sixty per cent of Australian employees prioritise flexible work over career progression, finds LifeWorks Mental Health Index™ MELBOURNE, Australia–(BUSINESS WIRE)–LifeWorks, a leading...
- 545Wire Stories
GAUSSIN Enters China, the Largest Truck Market in the World
GAUSSIN China to develop new partnerships to be a key player of the Green Mobility ecosystem in the country HÉRICOURT, France–(BUSINESS WIRE)–GAUSSIN...
- 545Wire Stories
Gold Resource Corporation Will Reschedule Its Fourth Quarter and Full Year 2021 Results
DENVER–(BUSINESS WIRE)–Gold Resource Corporation (NYSE American: GORO) (the “Company”) announced today that it is postponing the release of its fourth quarter and...
- 749Wire Stories
ExxonMobil and Papua New Guinea Sign P’nyang Gas Agreement
Agreement provides clear framework toward P’nyang project’s future development ExxonMobil-operated P’nyang project would link new upstream facilities in Western Province to existing...
- 569Wire Stories
Frazier Life Sciences Adds Highly Experienced Biopharmaceutical Executive to Team
MENLO PARK, Calif.–(BUSINESS WIRE)–Frazier Life Sciences announced the addition of Angie You, Ph.D. as a Senior Advisor. She most recently served as...
- 705Wire Stories
BeiGene Announces European Medicines Agency Acceptance of Applications for BRUKINSA (zanubrutinib) in Chronic Lymphocytic Leukemia and Marginal Zone Lymphoma
The CLL filing is supported by two global Phase 3 trials of BRUKINSA in chronic lymphocytic leukemia covering both treatment-naïve and relapsed...
- 570Wire Stories
Extreme Weather Testing for the Leapmotor T03 EV Shows Its Potential on the Market
HANGZHOU, China–(BUSINESS WIRE)–At 53°33?N and 135°05? E, the T03 model of Leapmotor had been tested in the harshest conditions. The tests included...
